The mutational landscape of early‐ and typical‐onset oral tongue squamous cell carcinoma

Abstract

Background The incidence of oral tongue squamous cell carcinoma (OTSCC) is increasing among younger birth cohorts. The etiology of early‐onset OTSCC (diagnosed before the age of 50 years) and cancer driver genes remain largely unknown. Methods The Sequencing Consortium of Oral Tongue Cancer was established through the pooling of somatic mutation data of oral tongue cancer specimens (n = 227 [107 early‐onset cases]) from 7 studies and The Cancer Genome Atlas. Somatic mutations at microsatellite loci and Catalog of Somatic Mutations in Cancer mutation signatures were identified. Cancer driver genes were identified with the MutSigCV and WITER algorithms. Mutation comparisons between early‐ and typical‐onset OTSCC were evaluated via linear regression with adjustments for patient‐related factors. Results Two novel driver genes (ATXN1 and CDC42EP1) and 5 previously reported driver genes (TP53, CDKN2A, CASP8, NOTCH1, and FAT1) were identified. Six recurrent mutations were identified, with 4 occurring in TP53. Early‐onset OTSCC had significantly fewer nonsilent mutations even after adjustments for tobacco use. No associations of microsatellite locus mutations and mutation signatures with the age of OTSCC onset were observed. Conclusions This international, multicenter consortium is the largest study to characterize the somatic mutational landscape of OTSCC and the first to suggest differences by age of onset. This study validates multiple previously identified OTSCC driver genes and proposes 2 novel cancer driver genes. In analyses by age, early‐onset OTSCC had a significantly smaller somatic mutational burden that was not explained by differences in tobacco use. Lay Summary This study identifies 7 specific areas in the human genetic code that could be responsible for promoting the development of tongue cancer. Tongue cancer in young patients (under the age of 50 years) has fewer overall changes to the genetic code in comparison with tongue cancer in older patients, but the authors do not think that this is due to differences in smoking rates between the 2 groups. The cause of increasing cases of tongue cancer in young patients remains unclear.

Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of EGFR Amplification: Implications for Novel Personalized Therapy

“…Our study is the first to identify lower TMB and EGFR amplification with associated increased RNA abundance in cases of OSCC <50 yearsa much advance towards personalized therapy, where the literature to date has recognized limited differences in OSCC patients <50 and ≥50 years (71)(72)(73). The genomic, transcriptomic and functional findings of this study provide evidence for testing EGFR CNV and pEGFR levels when designing future clinical trials utilizing EGFR targeted therapies.…”

Multidimensional Mutational Profiling of the Indian HNSCC Sub-Population Provides IRAK1, a Novel Driver Gene and Potential Druggable Target

“…The presence of a missense variant in a buccal mucosa tumor patient indicates that the mutation might be an inactivating mutation. Apart from TP53 , which has previously been identified as a driver gene in oral tongue squamous cell carcinoma ( 64 ), novel gene cluster specific to tongue cancer has been identified which needs validation in larger cohort..…”

Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial Cancer

“…Furthermore, we limited our analysis to nonsilent variants-including missense, frameshift, nonframeshift, splicing, nonsense, and truncating mutations-for the analyses of nonsilent mutation events (eg, bin variable for mutation carrier and noncarrier) and mutation frequencies, similar to our previous studies. [30][31][32] CONTEXT Key Objective Endometrial cancer (EC) is the sixth most commonly diagnosed cancer in women worldwide. Yet, unique to EC, disease incidence-particularly in younger patients and in developed countries-has been rapidly increasing in recent years.…”